Scientific notes

Restorative effect of adipose tissue-derived stem cells on impaired hepatocytes through Notch signaling in non-alcoholic steatohepatitis mice (Ishida et al, 2021)

Introduction

Adipose tissue-derived stem cells (ADSCs) are mesenchymal stem cells (MSCs) that are obtained from abundant adipose tissue, adherent on plastic culture flasks can be expanded in vitro, and have the capacity to differentiate into multiple cell lineages.

Unlike bone marrow-derived MSCs, ADSCs can be obtained from abundant adipose tissue by a minimally invasive procedure, which results in a high number of cells.

Nonalcoholic steatohepatitis (NASH) is liver inflammation and damage caused by a buildup of fat in the liver. It is part of a group of conditions called nonalcoholic fatty liver disease.

You may be told you have a “fatty liver.” Many people have a buildup of fat in the liver, and for most people, it causes no symptoms and no problems. But in some people, the fat causes inflammation and damages cells in the liver. Because of the damage, the liver doesn’t work as well as it should.

This study demonstrated the repairing/restorative effect of ADSC treatment on hepatocytes of NASH mice, which was mediated by Notch signaling. Further studies are required to confirm the therapeutic effect of ADSCs on NASH and the contribution of Notch signaling.

Understanding the molecular mechanisms underlying the repairing/restorative effect of ADSCs will contribute to the development of an effective therapeutic strategy for the treatment of emerging chronic liver disease, NASH.

How to culture vascularized & immunocompetent 3D models in a standard Multiwell

Abstract

The authors state that “Adipose tissue-derived stem cells (ADSCs) have been suggested as a novel treatment for non-alcoholic steatohepatitis (NASH); however, the mechanisms underlying their therapeutic effect remain poorly understood. In this study, we aimed to investigate the association of Notch signaling, which is crucial for cellular proliferation and differentiation in ADSC-mediated treatment of NASH.

Flow cytometry analysis of ADSCs showed that they expressed the Notch ligands JAG1, DLL1, and DLL4. The expression of genes associated with the Notch signaling pathway was attenuated in hepatocytes of NASH model mice. We further observed ADSC-mediated activation of Notch signaling in these hepatocytes in addition to an increase in proliferating cell nuclear antigen+ cells and a decrease in TdT-mediated dUTP-biotin nick-end labeling+ apoptotic cells.

Co-culture of palmitic acid-induced steatotic hepatocytes and ADSCs resulted in the activation of Notch signaling and reduction of apoptosis of steatotic hepatocytes. Moreover, inhibition of Notch signaling by a γ-secretase inhibitor and knockdown of Notch ligands using siRNA attenuated the anti-apoptotic effect of co-cultured ADSCs in vitro.

Our findings show that the Notch signaling pathway is involved in the inhibition of apoptosis and restoration of cellular proliferation of hepatocytes from NASH mice following ADSC treatment.”

References

Ishida, K., Seki, A., Kawaguchi, K., Nasti, A., Yamato, M., Inui, H., Komura, T., Yamashita, T., Arai, K., Yamashita, T., Mizukoshi, E., Honda, M., Wada, T., Harada, K., Kaneko, S., & Sakai, Y. (2021). Restorative effect of adipose tissue-derived stem cells on impaired hepatocytes through Notch signaling in non-alcoholic steatohepatitis mice. Stem Cell Research, 54, 102425. https://doi.org/10.1016/j.scr.2021.102425

Related Posts

Flowchart showing the steps used to create patient-derived tumor organoids (PDTOs): starting at left with a human silhouette and icons for “biological fluids” and “tumor”, followed by enzymatic/mechanical dissociation equipment; a tube containing isolated cells; embedding of cells in an extracellular-matrix dome inside a culture well; addition of enriched medium; formation of PDTOs; parallel branches for characterization (histology slide, sequencing machine), research assays (multi-well plate, radiation symbol, pill), and cryopreservation (vial rack); arrows trace feedback from PDTO characterization back to the original tumor to correlate findings.
Breast cancer organoid: A short history of innovation in breast c...
Breast cancer has long been one of the most prevalent and challenging cancers worldwide, demanding constant advances in treatment and resear...
Read more
Flat-style illustration showing research papers labeled “Liver,” each with pictograms related to metabolism and organoid research, including molecules, charts, and liver tissue icons, symbolizing scientific breakthroughs in liver organoid and liver-on-chip studies.
Top 10 Breakthrough Studies Using Liver Organoids and Liver-on-Ch...
Liver disease and drug-induced liver injury remain critical challenges in medicine and pharmaceutical development, demanding models that clo...
Read more
Cultivating gut microbiota on a gut-on-a-chip...
A complex human gut microbiome cultured in anaerobic intestine-on-a-chip A recently published paper on Nature biomedical engineering highl...
Read more

get in touch

Get the best insights about Cherry Biotech by Email Let’s stay in touch!
As part of our commercial prospecting, we may need to process your personal data. For more information, please consult our Privacy Policy